Answers are grounded in this paper and cite their sources.
Sleep disturbances, including reduced nocturnal sleep time, sleep fragmentation, nocturnal wandering, and daytime sleepiness are common clinical problems in dementia, and are associated with significant carer distress, increased healthcare costs, and institutionalisation. Although non-drug interventions are recommended as the first-line approach to managing these problems, drug treatment is often sought and used. However, there is significant uncertainty about the efficacy and adverse effects of the various hypnotic drugs in this clinically vulnerable population.
No takes yet. Share an insight, caveat, or question.
McCleery et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: